Multi-center MRD Registry for Inflammatory Breast Cancer
NCT06966050 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 200
Last updated 2026-05-20
Summary
To collect data from participants with IBC who may have had MRD testing and may have surgery in the future.
Conditions
Interventions
- BEHAVIORAL
-
Quality-of-life Questionnaire
Participants will be asked to fill out a quality-of-life questionnaire, which will take about 10-15 minutes to complete.
Sponsors & Collaborators
-
M.D. Anderson Cancer Center
lead OTHER
Principal Investigators
-
Sadia Saleem, MD · M.D. Anderson Cancer Center
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-05-05
- Primary Completion
- 2030-05-31
- Completion
- 2032-05-31
Countries
- United States
Study Locations
More Related Trials
-
Feasibility of Short Breast MRI (SBMRI) for Screening Patients at High Risk for Breast Cancer
NCT02590458 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Breast Cancer Registry for Participants With Breast Cancer or Characteristics of Hereditary Breast Cancer
NCT00666731 ·Status: COMPLETED
-
Observational Clinical Study on Role of MRD in Predicting Local Therapy in Oligometastatic Breast Cancer
NCT06918262 ·Status: RECRUITING
-
Molecular Breast Imaging (MBI)-Guided Biopsy
NCT07114679 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
The Use of Molecular Breast Imaging in the Evaluation of Tumor Response to Neoadjuvant Therapy in Women With Breast Cancer
NCT01023802 ·Status: COMPLETED
-
Screening in Myocardial Perfusion Patients
NCT00943241 ·Status: COMPLETED
-
Study to Evaluate the Diagnostic Value of a Combined Molecular Breast Imaging/ Breast Tomosynthesis Modality
NCT01024114 ·Status: WITHDRAWN
-
Surveillance MRI Registry for Patients Who Had Breast Cancer With Dense Breast Tissue
NCT06127797 ·Status: RECRUITING
-
Intensity Modulated Radiotherapy for Breast Cancer
NCT00594477 ·Status: COMPLETED ·Phase: PHASE1
-
Studying Blood and Tumor Tissue Samples in Women With Invasive Breast Cancer, Ductal or Lobular Carcinoma in Situ, or Benign Breast Disease
NCT00898508 ·Status: COMPLETED
-
Treatment Decision Making in African American Women Diagnosed With Triple Negative Breast Cancer
NCT05071677 ·Status: COMPLETED
-
Magnetic Resonance Imaging of Breast Cancer
NCT01035112 ·Status: RECRUITING ·Phase: NA
-
New Technique as an Additional Diagnostic Tool for Women Undergoing Neoadjuvant Therapy for Breast Cancer
NCT00566085 ·Status: COMPLETED ·Phase: NA
-
Tc99m Sestamibi Molecular Breast Imaging
NCT02324387 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
A Multi Modality Surveillance Program for Women At High Risk for Breast Cancer
NCT00989638 ·Status: ACTIVE_NOT_RECRUITING
-
Assessment of Quality of Life and Treatment Times for Patients With Invasive Type Breast Cancer in Martinique
NCT04918082 ·Status: ACTIVE_NOT_RECRUITING
-
Monitoring Response to Neoadjuvant Chemotherapy in HER2 Negative Breast Cancer Using High-speed MR Spectroscopic Imaging
NCT03568448 ·Status: ACTIVE_NOT_RECRUITING
-
Comparison of MRI and Molecular Breast Imaging in Breast Diagnostic Evaluation
NCT00591864 ·Status: COMPLETED ·Phase: NA
-
Refining Local-Regional Therapy for IBC
NCT04636710 ·Status: RECRUITING ·Phase: NA
-
Use of Molecular Breast Imaging (MBI) to Detect Additional Disease in Women With Breast Cancer Who Are About to go to Surgery
NCT00776308 ·Status: COMPLETED
-
Breast Imaging Studies in Women at High Genetic Risk of Breast Cancer: Menstrual Cycle Study
NCT00006425 ·Status: COMPLETED
-
Molecular Analysis of Breast Cancer
NCT00569049 ·Status: COMPLETED
-
Inflammatory Breast Cancer, Tumor Markers, and Factors Associated With Angiogenesis
NCT00646555 ·Status: COMPLETED
-
Biomarker Study of Breast Tumors
NCT00941408 ·Status: UNKNOWN
-
Evaluation of Prognostic Monitoring for Young Breast Cancer Patients
NCT04145986 ·Status: UNKNOWN